Skip to main content
logo
Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
10.61
+0.13 (1.24%)
At close: Aug 18, 2026, 4:00 PM EDT
10.50
-0.11 (-1.04%)
After-hours: Aug 18, 2026, 5:43 PM EDT

Keros Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-83.1687.01-187.35-152.99-104.68-58.74
Depreciation & Amortization
1.61.511.230.820.670.38
Loss (Gain) From Sale of Assets
0-0.01-00.010.05
Stock-Based Compensation
22.8728.734.8728.7618.6811.72
Other Operating Activities
2.522.411.821.550.940.52
Change in Accounts Receivable
15.82-0.83-2.6-0.1418-18
Change in Accounts Payable
-3.44-3-0.251.61-0.411.49
Change in Unearned Revenue
-0.93-----
Change in Income Taxes
-8.57-2.25----
Change in Other Net Operating Assets
5.3-6.04-8.59-4.12-3.280.45
Operating Cash Flow
-47.99107.51-160.87-124.51-70.06-62.15
Operating Cash Flow Growth
------
Capital Expenditures
-0.49-1.55-1.93-2.46-1.24-1.02
Investing Cash Flow
-0.49-1.55-1.93-2.46-1.24-1.02
Issuance of Common Stock
0.30.29392.28179.05120.428.55
Repurchase of Common Stock
-384.56-378.9----
Other Financing Activities
0.140.14-0.45-0.09-0.09-
Financing Cash Flow
-384.12-378.47391.82178.96120.3128.55
Net Cash Flow
-432.61-272.52229.0251.9849.01-34.62
Free Cash Flow
-48.49105.95-162.8-126.97-71.3-63.17
Free Cash Flow Growth
------
Free Cash Flow Margin
-322.94%43.41%-4585.91%-84087.42%--314.29%
Free Cash Flow Per Share
-1.812.80-4.35-4.31-2.83-2.71
Levered Free Cash Flow
-27.1766.24-108.31-81.25-33.84-39.48
Unlevered Free Cash Flow
-27.1766.24-108.31-81.25-33.84-39.48
Cash Income Tax Paid
5.657.15----
Change in Working Capital
8.18-12.11-11.44-2.6514.31-16.07
SEC Filings: 10-K · 10-Q